Clinical Trials Directory

Trials / Completed

CompletedNCT02032069

Pneumoproteins Expression in the Organ Donor

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
University Hospital of Mont-Godinne · Academic / Other
Sex
All
Age
5 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Primary graft dysfunction, a form of reperfusion pulmonary edema that occurs early after lung transplantation, shares key clinical and pathological features with acute lung injury and its more severe form, the acute respiratory distress syndrome. However, in contrast to acute lung injury/acute respiratory distress syndrome, in which biomarkers in plasma, urine and lung edema fluid have prognostic and pathogenetic value, the role of biomarkers in primary graft dysfunction has been less thoroughly explored. We will try in this study de determine the rule of pneumoproteins in the donor organ on the pulmonary edema in the recipient.

Conditions

Interventions

TypeNameDescription
OTHERno intervention

Timeline

Start date
2013-01-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2014-01-09
Last updated
2016-03-15

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02032069. Inclusion in this directory is not an endorsement.